Wiebelhaus Jason M, Walentiny D Matthew, Beardsley Patrick M
Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia.
Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, Virginia
J Pharmacol Exp Ther. 2016 Jan;356(1):43-52. doi: 10.1124/jpet.115.228940. Epub 2015 Oct 21.
Incidence of prescription opioid abuse and overdose, often led by oxycodone, continues to increase, producing twice as many overdose deaths as heroin. Surprisingly, preclinical reports relevant to oxycodone's abuse-related effects are relatively sparse considering its history and patient usage. The goal of this study was to characterize dose- and time-dependent effects of acute and repeated oxycodone administration in a frequency-rate intracranial self-stimulation (ICSS) procedure, an assay often predictive of drug-related reinforcing effects, in male Sprague-Dawley rats. We hypothesized that oxycodone would produce a biphasic profile of rate-increasing and rate-decreasing effects maintained by ICSS similar to μ-opioid receptor agonists. Oxycodone (0.03, 0.3, 1, and 3 mg/kg, s.c.) produced dose- and time-dependent alterations on ICSS, with the predicted biphasic profile of rate-increasing effects at lower stimulation frequencies followed by rate-decreasing effects at higher frequencies. Peak effects were observed between 30 and 60 minutes, which were reversed by naloxone pretreatment (30 minutes). Tolerance to rate-decreasing effects was observed over a 5-day period when rats were treated with 1 mg/kg oxycodone twice a day. Subsequently, the dosing regimen was increased to 3 mg/kg twice a day over 10 days, although further marked tolerance did not develop. When then challenged with 10 mg/kg naloxone, a significant suppression below baseline levels of ICSS-maintained responding occurred indicative of dependence that recovered to baseline within 5 hours. The results of this study provide the first report of acute and chronic effects of oxycodone on responding maintained by ICSS presentation and the use of ICSS-maintained responding to characterize its tolerance and dependence effects.
处方类阿片滥用和过量使用的发生率持续上升,其中常以羟考酮为主导,其导致的过量死亡人数是海洛因的两倍。令人惊讶的是,考虑到羟考酮的使用历史和患者使用情况,与羟考酮滥用相关效应的临床前报告相对较少。本研究的目的是在雄性斯普拉格-道利大鼠的频率-速率颅内自我刺激(ICSS)实验中,表征急性和重复给予羟考酮的剂量和时间依赖性效应,该实验通常可预测与药物相关的强化效应。我们假设羟考酮会产生类似于μ-阿片受体激动剂的、由ICSS维持的速率增加和速率降低效应的双相特征。羟考酮(0.03、0.3、1和3mg/kg,皮下注射)对ICSS产生剂量和时间依赖性改变,在较低刺激频率下呈现出预测的速率增加效应的双相特征,随后在较高频率下出现速率降低效应。在30至60分钟之间观察到峰值效应,纳洛酮预处理(30分钟)可逆转该效应。当大鼠每天两次接受1mg/kg羟考酮治疗时,在5天的时间内观察到对速率降低效应的耐受性。随后,给药方案在10天内增加到每天两次3mg/kg,尽管没有进一步出现明显的耐受性。当用10mg/kg纳洛酮进行激发时,ICSS维持反应的基线水平出现显著抑制,表明存在依赖性,且在5小时内恢复到基线水平。本研究结果首次报告了羟考酮对ICSS呈现维持的反应的急性和慢性效应,以及使用ICSS维持反应来表征其耐受性和依赖性效应。